1.34
price down icon12.42%   -0.19
pre-market  Vorhandelsmarkt:  1.33   -0.01   -0.75%
loading

Finanzdaten der Sana Biotechnology Inc-Aktie (SANA)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
22.19%
110.72
90.62 2.181 116.29 84.05
Operating Income/Loss
22.19%
-110.72
-90.62 -2.181 -116.29 -84.05
Income/Loss From Continuing Operations Before Tax
21.97%
-107.47
-88.12 0.984 -114.00 -82.12
Income/Loss From Continuing Operations After Tax
21.97%
-107.47
-88.12 0.984 -114.00 -82.12
Net Income/Loss
21.97%
-107.47
-88.12 0.984 -114.00 -82.12
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
23,115%
217.29
0.936 196.98 192.54 191.23
Diluted Average Shares
23,115%
217.29
0.936 200.47 192.54 191.23
Basic Earnings Per Share
8.89%
-0.49
-0.45 - -0.59 -0.43
Diluted Earnings Per Share
8.89%
-0.49
-0.45 - -0.59 -0.43
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$17.98
price down icon 1.15%
$64.97
price down icon 4.58%
$16.64
price down icon 3.93%
$30.85
price down icon 0.58%
$86.65
price down icon 0.20%
biotechnology ONC
$209.41
price down icon 5.05%
Kapitalisierung:     |  Volumen (24h):